These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35561428)

  • 1. COVID-19 mRNA vaccine-associated encephalopathy, myocarditis, and thrombocytopenia with excellent response to methylprednisolone: A case report.
    Asaduzzaman M; Purkayastha B; Alam MMJ; Chakraborty SR; Roy S; Ahmed N
    J Neuroimmunol; 2022 Jul; 368():577883. PubMed ID: 35561428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine.
    Park S; You J
    J Korean Med Sci; 2022 Apr; 37(16):e131. PubMed ID: 35470603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.
    Buchan SA; Seo CY; Johnson C; Alley S; Kwong JC; Nasreen S; Calzavara A; Lu D; Harris TM; Yu K; Wilson SE
    JAMA Netw Open; 2022 Jun; 5(6):e2218505. PubMed ID: 35749115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
    Pillay J; Gaudet L; Wingert A; Bialy L; Mackie AS; Paterson DI; Hartling L
    BMJ; 2022 Jul; 378():e069445. PubMed ID: 35830976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events following COVID-19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia.
    Yasmin F; Najeeb H; Naeem U; Moeed A; Atif AR; Asghar MS; Nimri N; Saleem M; Bandyopadhyay D; Krittanawong C; Fadelallah Eljack MM; Tahir MJ; Waqar F
    Immun Inflamm Dis; 2023 Mar; 11(3):e807. PubMed ID: 36988252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine: A Case Report.
    Al-Rasbi S; Al-Maqbali JS; Al-Farsi R; Al Shukaili MA; Al-Riyami MH; Al Falahi Z; Al Farhan H; Al Alawi AM
    Am J Case Rep; 2022 Feb; 23():e934399. PubMed ID: 35173141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
    Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
    BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.
    Montgomery J; Ryan M; Engler R; Hoffman D; McClenathan B; Collins L; Loran D; Hrncir D; Herring K; Platzer M; Adams N; Sanou A; Cooper LT
    JAMA Cardiol; 2021 Oct; 6(10):1202-1206. PubMed ID: 34185045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity Reaction.
    Ameratunga R; Woon ST; Sheppard MN; Garland J; Ondruschka B; Wong CX; Stewart RAH; Tatley M; Stables SR; Tse RD
    J Clin Immunol; 2022 Apr; 42(3):441-447. PubMed ID: 34978002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
    Oster ME; Shay DK; Su JR; Gee J; Creech CB; Broder KR; Edwards K; Soslow JH; Dendy JM; Schlaudecker E; Lang SM; Barnett ED; Ruberg FL; Smith MJ; Campbell MJ; Lopes RD; Sperling LS; Baumblatt JA; Thompson DL; Marquez PL; Strid P; Woo J; Pugsley R; Reagan-Steiner S; DeStefano F; Shimabukuro TT
    JAMA; 2022 Jan; 327(4):331-340. PubMed ID: 35076665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A rare case of myocarditis and pulmonary embolism after BNT162b2 mRNA vaccine].
    Mancini N; Cortigiani L; Aquaro G; Bovenzi FM
    G Ital Cardiol (Rome); 2022 Apr; 23(4):244-246. PubMed ID: 35343473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination.
    Kim HW; Jenista ER; Wendell DC; Azevedo CF; Campbell MJ; Darty SN; Parker MA; Kim RJ
    JAMA Cardiol; 2021 Oct; 6(10):1196-1201. PubMed ID: 34185046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine.
    Azir M; Inman B; Webb J; Tannenbaum L
    J Emerg Med; 2021 Dec; 61(6):e129-e132. PubMed ID: 34756746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
    Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocarditis Following COVID-19 Vaccination: A Systematic Review (October 2020-October 2021).
    Lee ASY; Balakrishnan IDD; Khoo CY; Ng CT; Loh JKX; Chan LL; Teo LLY; Sim DKL
    Heart Lung Circ; 2022 Jun; 31(6):757-765. PubMed ID: 35227610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children.
    Dionne A; Sperotto F; Chamberlain S; Baker AL; Powell AJ; Prakash A; Castellanos DA; Saleeb SF; de Ferranti SD; Newburger JW; Friedman KG
    JAMA Cardiol; 2021 Dec; 6(12):1446-1450. PubMed ID: 34374740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series.
    Fazlollahi A; Zahmatyar M; Noori M; Nejadghaderi SA; Sullman MJM; Shekarriz-Foumani R; Kolahi AA; Singh K; Safiri S
    Rev Med Virol; 2022 Jul; 32(4):e2318. PubMed ID: 34921468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine.
    Park J; Brekke DR; Bratincsak A
    Cardiol Young; 2022 Jan; 32(1):146-149. PubMed ID: 34180390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute cardiac side effects after COVID-19 mRNA vaccination: a case series.
    Freise NF; Kivel M; Grebe O; Meyer C; Wafaisade B; Peiper M; Zeus T; Schmidt J; Neuwahl J; Jazmati D; Luedde T; Bölke E; Feldt T; Jensen BEO; Bode J; Keitel V; Haussmann J; Tamaskovics B; Budach W; Fischer JC; Knoefel WT; Schneider M; Gerber PA; Pedoto A; Häussinger D; van Griensven M; Rezazadeh A; Flaig Y; Kirchner J; Antoch G; Schelzig H; Matuschek C
    Eur J Med Res; 2022 Jun; 27(1):80. PubMed ID: 35655235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.